"DAPK1" Related Products

Expand
Expand

Recombinant Human DAPK1

Cat.No.: DAPK1-27363TH
Product Overview: Recombinant fragment, corresponding to amino acids 1-363 of Human DAP Kinase 1, expressed by baculovirus in Sf9 insect cells using an N-terminal enzyme tag.
Description: Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death.DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites. It is a tumor suppressor candidate.
Biological activity: Specific activity: 49 nmol/min/mg.
Form: Liquid
Storage buffer: Preservative: NoneConstituents: 25% Glycerol, 50mM Tris HCl, 150mM Sodium chloride, 0.25mM DTT, 0.1mM EGTA, 0.1mM EDTA, 0.1mM PMSF, pH 7.5
Storage: Shipped on dry ice. Upon delivery aliquot and store at -80oC. Avoid freeze / thaw cycles.
Sequence Similarities: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily.Contains 10 ANK repeats.Contains 1 death domain.Contains 1 protein kinase domain.
Gene Name: DAPK1 death-associated protein kinase 1 [ Homo sapiens ]
Official Symbol: DAPK1
Synonyms: DAPK1; death-associated protein kinase 1; DAPK;
Gene ID: 1612
mRNA Refseq: NM_004938
Protein Refseq: NP_004929
MIM: 600831
Uniprot ID: P53355
Chromosome Location: 9q34.1
Pathway: Apoptosis, organism-specific biosystem; Bladder cancer, organism-specific biosystem; Bladder cancer, conserved biosystem; IFN-gamma pathway, organism-specific biosystem; Pathways in cancer, organism-specific biosystem;
Function: ATP binding; calmodulin binding; nucleotide binding; protein binding; protein serine/threonine kinase activity;

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.